首页 | 本学科首页   官方微博 | 高级检索  
     


EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade
Authors:Anand Narayanan  Friedrich D. Knollmann  Julie Ann S. Walby  Steffany Lim  David R. Gandara  Jonathan W. Riess
Affiliation:1. UC Davis School of Medicine, Sacramento, CA;2. Department of Radiology, UC Davis School of Medicine, Sacramento, CA;3. Department of Pathology, UC Davis School of Medicine, Sacramento, CA;4. Department of Internal Medicine, Division of Hematology/Oncology, UC Davis School of Medicine and UC Davis Comprehensive Cancer Center, Sacramento, CA
Abstract:
Keywords:Address for correspondence: Jonathan W. Riess, MD, MS, Department of Internal Medicine, Division of Hematology/Oncology, UC Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA 95817  Atezolizumab  EBV-positive malignancy  Immunotherapy  PD-L1 antibody  Pulmonary lymphoepithelioma-like carcinoma
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号